Effectiveness and Safety of Treatment With Risankizumab in Patients With Crohn's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risankizumab Effectiveness and Safety in Crohn's Disease: Real-world Data From a Large Tertiary Center
Clin. Gastroenterol. Hepatol. 2024 Jun 01;22(6)1336-1338.e2, A Zinger, D Choi, N Choi, RD Cohen, DT RubinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.